Nikhil Lalwani, President and Chief Executive Officer

Mr. Lalwani is ANI’s President and Chief Executive Officer and a member of ANI’s Board. Prior to joining ANI in September 2020, Mr. Lalwani worked at Cipla Ltd (NSE: CIPLA), a global pharmaceutical company, from May 2012 to August 2020 where he held positions of increasing responsibility, including CEO of Cipla USA, CEO of InvaGen, Head of US Strategy, M&A & Integration, and Head of Cipla’s Global Respiratory business. In these roles, Mr. Lalwani developed and executed multi-year strategic growth plans for key products and facilitated successful acquisitions as Cipla entered the specialty pharmaceutical space. Prior to Cipla, Mr. Lalwani was an Associate Partner with McKinsey & Company serving pharmaceutical and healthcare companies across the world, and an engineer with Medtronic. Mr. Lalwani holds a B.S. in Electrical Engineering from Georgia Institute of Technology and an M.B.A. from the Wharton School at the University of Pennsylvania.

Stephen P. Carey, Vice President and Chief Financial Officer

Mr. Carey leads the company’s finance, accounting and information technology functions. Mr. Carey joined ANI in May 2016 as an accomplished executive with over 20 years of experience in finance and accounting, including 15 years of experience in the pharmaceutical industry. Previously, Mr. Carey served as Senior Vice President, Controller and Principal Accounting Officer of Par Pharmaceutical Companies, Inc., a generic and specialty pharmaceutical company. During his tenure at Par, Mr. Carey supported the company through significant growth, multiple M&A transactions and a public to private equity transaction. Prior to Par, Mr. Carey held various accounting and finance roles at Schering Plough Corporation (now Merck & Co.). Mr. Carey is a CPA (inactive) and began his career at PricewaterhouseCoopers. Mr. Carey holds a B.S. degree in Accounting from Montclair State University.

James G. Marken, Sr. Vice President, Operations and Product Development

Mr. Marken provides leadership for the production, engineering and logistics functions for the company's multi-site prescription drug, and potent compound facilities in Baudette, Minnesota. Mr. Marken brings over 20 years of pharmaceutical industry experience to his position. Prior to joining ANI Pharmaceuticals in 2007 as General Manager of the Minnesota facilities, he worked for Solvay Pharmaceuticals in various departments including Quality Control, Validation and Manufacturing. Mr. Marken holds a B.S. degree in Chemistry from Bemidji State University.

Robert Schrepfer, Sr. Vice President, Business Development and Specialty Sales

Mr. Schrepfer is responsible for identifying and advancing ANI's product pipeline and contract manufacturing opportunities. Prior to joining ANI, Mr. Schrepfer served as Managing Director and Assistant Portfolio Manager at Healthcare Value Capital, a healthcare investment firm, since 2005. Previously, Mr. Schrepfer was Vice President, Equity Research covering the Major and Specialty Pharmaceuticals sector at Bear Stearns & Cos, Inc. Mr. Schrepfer is a Member of the Health Sector Advisory Council at Duke University where he earned his MBA in Finance and Health Sector Management.